Vaismoradi Mojtaba, Logan Patricia A, Jordan Sue, Sletvold Hege
Faculty of Nursing and Health Sciences, Nord University, 8049 Bodø, Norway.
Faculty of Science, Charles Sturt University, Bathurst, NSW 2795, Australia.
Pharmacy (Basel). 2019 Jul 25;7(3):102. doi: 10.3390/pharmacy7030102.
Prescription medicines aim to relieve patients' suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and collective knowledge on ADR reporting and monitoring in the Norwegian healthcare system. Accordingly, this systematic review aims to investigate the current trends in ADR reporting, monitoring, and handling in the Norwegian healthcare system and describe related interventions. Appropriate keywords, with regard to ADRs in both English and Norwegian languages, were used to retrieve articles published from 2010 to 2019. Six articles met the inclusion criteria. The findings offer a comprehensive picture of ADR reporting and monitoring in the Norwegian healthcare system. Psychotropic medicines were most commonly implicated by patients, while professionals most commonly reported ADRs associated with anticoagulants. The current ADR systems were compiled with the involvement of both patients and healthcare providers to record all types of drugs and ADRs of various severities, and aimed at improving ADR tracking. However, there is a need to improve current initiatives in terms of feedback and quality, and more studies are needed to explore how ADR profiles, and the associated vigilance, can improve the safety of medicines management in Norway.
处方药旨在减轻患者的痛苦,但它们可能会带来不良副作用或药物不良反应(ADR)。药物不良反应是导致患者住院的一个重要原因,也是全球医疗系统的一项经济负担。在挪威医疗系统中,关于药物不良反应报告和监测的综合和集体知识很少。因此,本系统综述旨在调查挪威医疗系统中药物不良反应报告、监测和处理的当前趋势,并描述相关干预措施。使用了关于药物不良反应的英文和挪威文的适当关键词,检索2010年至2019年发表的文章。有六篇文章符合纳入标准。研究结果全面呈现了挪威医疗系统中药物不良反应报告和监测的情况。患者提及最多的是精神药物,而专业人员报告最多的是与抗凝剂相关的药物不良反应。当前的药物不良反应系统是在患者和医疗服务提供者的参与下编制的,用于记录所有类型的药物和各种严重程度的药物不良反应,旨在改善药物不良反应的跟踪。然而,在反馈和质量方面需要改进当前的举措,还需要更多研究来探索药物不良反应概况以及相关的警惕性如何能够提高挪威药品管理的安全性。